Trial Profile
First phase III study of Siquimod in Europe in healthy volunteers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Resiquimod (Primary)
- Indications Herpes simplex virus infections
- Focus Therapeutic Use
- 27 Nov 2015 New trial record